Maze Therapeutics, Inc. (MAZE): SCHEDULE 13G/A filed Feb 13, 2026

Form type

SCHEDULE 13G/A

Filing date

Feb 13, 2026

Accession number

0001193125-26-051800

Filer

Maze Therapeutics, Inc. (CIK 1842295)